Skip to content

Shares (Basic) at other companies

Eli Lilly logo
Eli LillyLLY
894.5M-0.5%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
105.5M+48.5%
Opko Health logo
Opko HealthOPK
758.9M+13.0%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
63.1M+9.0%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
15.6M+0.8%
Erasca, Inc. logo
Erasca, Inc.ERAS
304.3M+7.4%

Other financials

Income statement

See full
Operating income-$58.0M-66.3%
Net income-$53.1M-74.7%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$52.5M+3.8%
Total debt$956.0K-16.7%
Total equity$480.5M+25.3%
Total assets$530.6M+29.5%

Cash flow

See full
Operating cash flow-$46.0M-4.6%
CapEx-
Free cash flow-$34.5M-27.8%

Valuation

See full
Market cap$973.05M+244%
Enterprise value$921.46M+295%

Returns & leverage

See full
Return on equity-42.9%+1.3pp
Debt / equity0.0×
Current ratio10.9×-4.3×

Where this comes from

Reported directly by Olema Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Olema Pharmaceuticals, Inc.'s shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Olema Pharmaceuticals, Inc.'s shares (basic)?
Olema Pharmaceuticals, Inc. (OLMA) reported shares (basic) of 102.8M in Q1 2026.
How has Olema Pharmaceuticals, Inc.'s shares (basic) changed year-over-year?
Olema Pharmaceuticals, Inc.'s shares (basic) increased by 20.3% year-over-year, from 85.4M to 102.8M.
What is the long-term trend for Olema Pharmaceuticals, Inc.'s shares (basic)?
Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s shares (basic) has grown at a 21.5% compound annual growth rate (CAGR), from 157.9M to 343.7M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.